PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,387 | -13.3% | 45,243 | +13.3% | 0.00% | -25.0% |
| Q2 2023 | $1,599 | -24.3% | 39,947 | -22.9% | 0.00% | -20.0% |
| Q1 2023 | $2,113 | +17.0% | 51,792 | +10.7% | 0.01% | 0.0% |
| Q4 2022 | $1,806 | -99.9% | 46,767 | -7.2% | 0.01% | -37.5% |
| Q3 2022 | $2,681,000 | +2.9% | 50,399 | +12.8% | 0.01% | +14.3% |
| Q2 2022 | $2,606,000 | -13.6% | 44,699 | +16.1% | 0.01% | +16.7% |
| Q1 2022 | $3,016,000 | +31.0% | 38,506 | +0.4% | 0.01% | +20.0% |
| Q4 2021 | $2,303,000 | +7.9% | 38,360 | +1.4% | 0.01% | 0.0% |
| Q3 2021 | $2,135,000 | -7.1% | 37,838 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,297,000 | -13.2% | 37,838 | +0.2% | 0.01% | -16.7% |
| Q1 2021 | $2,645,000 | +4.8% | 37,764 | -10.5% | 0.01% | +20.0% |
| Q4 2020 | $2,524,000 | -10.5% | 42,183 | -10.2% | 0.01% | -16.7% |
| Q3 2020 | $2,819,000 | +5.5% | 46,953 | -8.0% | 0.01% | 0.0% |
| Q2 2020 | $2,671,000 | +45.4% | 51,017 | -7.1% | 0.01% | +20.0% |
| Q1 2020 | $1,837,000 | -19.3% | 54,931 | +8.4% | 0.01% | 0.0% |
| Q4 2019 | $2,276,000 | +1313.7% | 50,692 | +1266.7% | 0.01% | – |
| Q2 2019 | $161,000 | -21.1% | 3,709 | -30.9% | 0.00% | -100.0% |
| Q1 2019 | $204,000 | -8.1% | 5,364 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $222,000 | +18.1% | 5,364 | +39.9% | 0.00% | – |
| Q3 2018 | $188,000 | +52.8% | 3,835 | 0.0% | 0.00% | – |
| Q2 2018 | $123,000 | +2.5% | 3,835 | 0.0% | 0.00% | – |
| Q1 2018 | $120,000 | -31.4% | 3,835 | 0.0% | 0.00% | – |
| Q4 2017 | $175,000 | +18.2% | 3,835 | 0.0% | 0.00% | – |
| Q3 2017 | $148,000 | -18.7% | 3,835 | 0.0% | 0.00% | – |
| Q2 2017 | $182,000 | +4.6% | 3,835 | 0.0% | 0.00% | – |
| Q1 2017 | $174,000 | +40.3% | 3,835 | 0.0% | 0.00% | – |
| Q4 2016 | $124,000 | -52.7% | 3,835 | -50.0% | 0.00% | – |
| Q3 2016 | $262,000 | +103.1% | 7,670 | +100.0% | 0.00% | – |
| Q2 2016 | $129,000 | -36.5% | 3,835 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $203,000 | -31.2% | 3,835 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $295,000 | +86.7% | 3,835 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $158,000 | -41.7% | 3,835 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $271,000 | +21.0% | 3,835 | +51.3% | 0.00% | 0.0% |
| Q1 2015 | $224,000 | 0.0% | 2,535 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $224,000 | -9.3% | 2,535 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $247,000 | +58.3% | 2,535 | +49.1% | 0.00% | 0.0% |
| Q2 2014 | $156,000 | +32.2% | 1,700 | 0.0% | 0.00% | – |
| Q1 2014 | $118,000 | +20.4% | 1,700 | 0.0% | 0.00% | – |
| Q4 2013 | $98,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |